M. Samadi

The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial

M. Qorbani, Asieh Mansour, M. Mohajeri-Tehrani, 2020, Frontiers in Endocrinology.

Effect of Oligopin Supplementation on Polycystic Ovary Syndrome: A Randomized Controlled Trial

M. Qorbani, Asieh Mansour, M. Mohajeri-Tehrani, 2020 .

Adherence to Healthy Eating Index-2015 and severity of disease in hospitalised military patients with COVID-19: a cross sectional study

M. Sepandi, M. Taghdir, K. Parastouei, 2022, BMJ military health.

Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients

H. Poustchi, M. Qorbani, Asieh Mansour, 2019, Acta Diabetologica.

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial

H. Poustchi, M. Qorbani, S. Merat, 2021, Nutrition Journal.

Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS.

M. Qorbani, Asieh Mansour, M. Mohajeri-Tehrani, 2021, Clinical nutrition.

Effect of resveratrol administration on ovarian morphology, determined by transvaginal ultrasound for the women with polycystic ovary syndrome (PCOS)

M. Qorbani, Asieh Mansour, M. Mohajeri-Tehrani, 2021, British Journal of Nutrition.

Effect of resveratrol administration on ovarian morphology, determined by transvaginal ultrasound in patients with PCOS

M. Qorbani, Asieh Mansour, M. Mohajeri-Tehrani, 2019 .